FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306702005> ?p ?o ?g. }

• W4306702005 endingPage "2762" @default.
• W4306702005 startingPage "2754" @default.
• W4306702005 abstract "DESTINY-Breast01 (NCT03248492) evaluated trastuzumab deruxtecan (T-DXd; DS-8201) in patients with heavily pretreated HER2-positive metastatic breast cancer (mBC). We present a subgroup of 24 patients with a history of treated brain metastases (BM), a population with limited treatment options. In patients with BMs, the confirmed objective response rate (cORR) was 58.3% [95% confidence interval (CI), 36.6%-77.9%], and the median progression-free survival (mPFS) was 18.1 months (95% CI, 6.7-18.1 months). In patients without BMs (n = 160), cORR was 61.3% and mPFS was 16.4 months. Eight patients (47.1%) experienced a best overall intracranial response of partial response or complete response. Seven patients (41.2%) had a best percentage change in brain lesion diameter from baseline consistent with stable disease. Two patients (8.3%) with BMs and two (1.3%) without BMs experienced progression in the brain. The safety profile of T-DXd was consistent with previous studies. The durable clinical activity of T-DXd in this population warrants further investigation.Advances in treating HER2-positive metastatic breast cancer have greatly improved patient outcomes, but intracranial progression remains an important risk for which few therapeutic options are currently available. T-DXd demonstrated durable efficacy in patients with stable, treated BMs. This article is highlighted in the In This Issue feature, p. 2711." @default.
• W4306702005 created "2022-10-19" @default.
• W4306702005 creator A5005398528 @default.
• W4306702005 creator A5022448589 @default.
• W4306702005 creator A5026459010 @default.
• W4306702005 creator A5030456956 @default.
• W4306702005 creator A5032785430 @default.
• W4306702005 creator A5034917686 @default.
• W4306702005 creator A5041726660 @default.
• W4306702005 creator A5055791583 @default.
• W4306702005 creator A5056844302 @default.
• W4306702005 creator A5066221687 @default.
• W4306702005 creator A5068059897 @default.
• W4306702005 creator A5068943042 @default.
• W4306702005 creator A5073787373 @default.
• W4306702005 creator A5076447745 @default.
• W4306702005 creator A5079509906 @default.
• W4306702005 creator A5082195410 @default.
• W4306702005 creator A5083945008 @default.
• W4306702005 creator A5088057801 @default.
• W4306702005 date "2022-10-18" @default.
• W4306702005 modified "2023-09-30" @default.
• W4306702005 title "Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis" @default.
• W4306702005 cites W2013669698 @default.
• W4306702005 cites W2019607817 @default.
• W4306702005 cites W2045134790 @default.
• W4306702005 cites W2114080253 @default.
• W4306702005 cites W2314772071 @default.
• W4306702005 cites W2374911498 @default.
• W4306702005 cites W2519946849 @default.
• W4306702005 cites W2590127648 @default.
• W4306702005 cites W2907345836 @default.
• W4306702005 cites W2995808512 @default.
• W4306702005 cites W2996630100 @default.
• W4306702005 cites W3018222852 @default.
• W4306702005 cites W3025134199 @default.
• W4306702005 cites W3030461309 @default.
• W4306702005 cites W3039853672 @default.
• W4306702005 cites W3119128530 @default.
• W4306702005 cites W3176149878 @default.
• W4306702005 cites W3202728591 @default.
• W4306702005 cites W4200453601 @default.
• W4306702005 cites W4226051140 @default.
• W4306702005 cites W4281619692 @default.
• W4306702005 cites W4281640394 @default.
• W4306702005 cites W4281761766 @default.
• W4306702005 cites W4290673816 @default.
• W4306702005 cites W4294958620 @default.
• W4306702005 doi "https://doi.org/10.1158/2159-8290.cd-22-0837" @default.
• W4306702005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36255231" @default.
• W4306702005 hasPublicationYear "2022" @default.
• W4306702005 type Work @default.
• W4306702005 citedByCount "18" @default.
• W4306702005 countsByYear W43067020052021 @default.
• W4306702005 countsByYear W43067020052022 @default.
• W4306702005 countsByYear W43067020052023 @default.
• W4306702005 crossrefType "journal-article" @default.
• W4306702005 hasAuthorship W4306702005A5005398528 @default.
• W4306702005 hasAuthorship W4306702005A5022448589 @default.
• W4306702005 hasAuthorship W4306702005A5026459010 @default.
• W4306702005 hasAuthorship W4306702005A5030456956 @default.
• W4306702005 hasAuthorship W4306702005A5032785430 @default.
• W4306702005 hasAuthorship W4306702005A5034917686 @default.
• W4306702005 hasAuthorship W4306702005A5041726660 @default.
• W4306702005 hasAuthorship W4306702005A5055791583 @default.
• W4306702005 hasAuthorship W4306702005A5056844302 @default.
• W4306702005 hasAuthorship W4306702005A5066221687 @default.
• W4306702005 hasAuthorship W4306702005A5068059897 @default.
• W4306702005 hasAuthorship W4306702005A5068943042 @default.
• W4306702005 hasAuthorship W4306702005A5073787373 @default.
• W4306702005 hasAuthorship W4306702005A5076447745 @default.
• W4306702005 hasAuthorship W4306702005A5079509906 @default.
• W4306702005 hasAuthorship W4306702005A5082195410 @default.
• W4306702005 hasAuthorship W4306702005A5083945008 @default.
• W4306702005 hasAuthorship W4306702005A5088057801 @default.
• W4306702005 hasBestOaLocation W43067020051 @default.
• W4306702005 hasConcept C121608353 @default.
• W4306702005 hasConcept C126322002 @default.
• W4306702005 hasConcept C141071460 @default.
• W4306702005 hasConcept C143998085 @default.
• W4306702005 hasConcept C187960798 @default.
• W4306702005 hasConcept C2775930923 @default.
• W4306702005 hasConcept C2778164965 @default.
• W4306702005 hasConcept C2779013556 @default.
• W4306702005 hasConcept C2779786085 @default.
• W4306702005 hasConcept C2908647359 @default.
• W4306702005 hasConcept C44249647 @default.
• W4306702005 hasConcept C530470458 @default.
• W4306702005 hasConcept C71924100 @default.
• W4306702005 hasConcept C90924648 @default.
• W4306702005 hasConcept C99454951 @default.
• W4306702005 hasConceptScore W4306702005C121608353 @default.
• W4306702005 hasConceptScore W4306702005C126322002 @default.
• W4306702005 hasConceptScore W4306702005C141071460 @default.
• W4306702005 hasConceptScore W4306702005C143998085 @default.
• W4306702005 hasConceptScore W4306702005C187960798 @default.
• W4306702005 hasConceptScore W4306702005C2775930923 @default.
• W4306702005 hasConceptScore W4306702005C2778164965 @default.

• next